Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Platinum-based Anticancer Drugs). The latter disrupts mutant DNA by interstrand attachment to two adjacent guanine bases. Previously, it had been believed that the carboxylato complexes could not biud to DNA in this fashion. This may prompt further investigation of the antitumor activity of the rhodium complexes, which induce fewer harmful side effects than the platinum complexes. [Pg.4065]

See other pages where Rhodium complexes anticancer drugs is mentioned: [Pg.67] [Pg.521] [Pg.7214] [Pg.200] [Pg.306] [Pg.371] [Pg.201]

See also in sourсe #XX -- [ Pg.758 ]

See also in sourсe #XX -- [ Pg.758 ]

See also in sourсe #XX -- [ Pg.6 , Pg.758 ]